NextGen Healthcare Inc. (NASDAQ:NXGN) finished Wednesday with an addition of $0.88 to close at $17.24, an upside of 5.38 percent. An average of 820,360 shares of common stock have been traded in the last five days. There was a gain of $0.88 in the past week, and it reached a new high 12 times over the past 12 months. The last 20 days have seen an average of 390,710 shares traded, while the 50-day average volume stands at 369,204.
NXGN stock has increased by 6.68% in the last month. The company shares reached their 1-month lowest point of $15.52 on 07/25/23. With the stock rallying to its 52-week high on 02/15/23, shares of the company touched a low of $15.23 and a high of $21.99 in 52 weeks. It has reached a new high 5 times so far this year and lost -8.20% or -$1.54 in price. In spite of this, the price is down -21.60% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
NXGN stock investors should be aware that NextGen Healthcare Inc. (NXGN) stock had its last reported insider trading activity 266 days ago on Dec 01. In this transaction, the insider spent $666,135. EVP, Commercial Growth, Waters Mitchell, disposed of 9,783 shares at a price of $20.50 on Nov 08. The insider now owns more than $200,552 worth of shares. Prior to that, Chief Technology Officer Metcalfe David A went on to Sale 32,372 shares at $20.00 each on Nov 01. An amount of $647,485 was transacted.
Valuation Metrics
NextGen Healthcare Inc. (NXGN) has a trailing price-to-earnings (P/E) ratio of 689.60. The stock’s beta is 0.99. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.70, the price-to-book (PB) ratio at 2.79, and the price-to-cash flow ratio at 312.46.
Financial Health
The quick ratio of NextGen Healthcare Inc. for the three months ended June 29 was 2.20, and the current ratio was 2.20, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.65 and a total debt to equity ratio of 0.65 for the quarter ending June 29. NextGen Healthcare Inc.’s EBITDA margin for the year ending June 29 is 6.63%, while its operating margin for the same period stands at 0.60%. Its gross profit as reported stood at $311.16 million compared to revenue of $653.17 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, NextGen Healthcare Inc.’s return on assets was 0.30%.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $6.16 million in the quarter, while revenues of -$25.24 million were grew 81.33%. The analyst consensus anticipated NextGen Healthcare Inc.’s latest quarter earnings to come in at $0.22 per share, but it turned out to be $0.24, a 9.10% surprise. For the quarter, EBITDA amounted to $17.83 million. Shareholders own equity worth $67.02 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at NextGen Healthcare Inc. (NXGN) price momentum. RSI 9-day as of the close on 23 August was 68.09%, suggesting the stock is Neutral, with historical volatility in this time frame at 32.37%.
As of today, NXGN’s price is $16.43 +5.38% or $0.88 from its 5-day moving average. NXGN is currently trading +6.49% higher than its 20-day SMA and +0.70% higher than its 100-day SMA. However, the stock’s current price level is +4.80% above the SMA50 and -12.35% below the SMA200.
The stochastic %K and %D were 35.19% and 19.75%, respectively, and the average true range (ATR) was 0.48. With the 14-day stochastic at 61.11% and the average true range at 0.45, the RSI (14) stands at 62.99%. The stock has reached 0.03 on the 9-day MACD Oscillator while the 14-day reading was at -0.04.
Analyst Ratings
Stephens launched coverage on NextGen Healthcare Inc. (NASDAQ: NXGN) in its analyst report released on April 12, 2023. The firm assigned the stock an Overweight rating. The consensus rating for NextGen Healthcare Inc. (NXGN) among analysts is Hold. According to current brokerage recommendations, 1 brokerage firm advise that investors sell NXGN, while 5 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.
What is NXGN’s price target for the next 12 months?
Analysts predict a range of price targets between $16.00 and $25.00, with a median target of $19.50. Taking a look at these predictions, the average price target given by analysts for NextGen Healthcare Inc. (NXGN) stock is $20.00.
